TLR4 Antikörper
Kurzübersicht für TLR4 Antikörper (ABIN1106216)
Target
Alle TLR4 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Spezifität
- This antibody detects reacts with the TLR4/MD-2 complex.
-
Kreuzreaktivität (Details)
- Species reactivity (tested):Human
-
Aufreinigung
- Protein G
-
Immunogen
- TLR4/MD-2 expressing CHO cells/ chimeric TLR4/MD-2 fusion protein
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 0.1 mg/mL
-
Buffer
- PBS, 0.1 % bovine serum albumin
-
Konservierungsmittel
- Azide free
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store at 2 - 8 °C.
-
-
- TLR4 (Toll-Like Receptor 4 (TLR4))
-
Andere Bezeichnung
- CD284 / TLR4
-
Hintergrund
- TLRs belong to a family of proteins that specifically recognizes and senses microbial products. They are highly conserved throughout evolution and act as innate immune recognition receptors against many pathogens. TLR4 is a functional receptor for gram-negative bacterial lipopolysaccharides (LPS). TLR4 associates with MD-2 which is absolutely required for LPS-induced activation of TLR4.MD-2 exists as a cell surface protein in association with TLR4. It also exists as secreted forms consisting of MD-2 monomers and multimers (sMD-2). Circulating sMD-2 is mainly present as a doublet of ~20 and 25 kD, representing differentially glycosylated forms. Unlike TLR4, sMD-2 binds directly LPS without the need of soluble CD14 (sCD14). However, LPS-MD-2 interactions are increased when LPS is pretreated with CD14. Only monomeric sMD-2 is biologically active and able to associate with TLR4 and LPS. sMD-2 circulates in plasma of healthy individuals as a non-active, polymeric protein. In septic plasma, the total amount of sMD-2 was strongly elevated and contained both sMD-2 polymers and monomers. Soluble MD-2 is proposed to be an important mediator of organ inflammation during sepsis. During experimental human endotoxemia, the monomeric and total sMD-2 content in plasma increased with the kinetics of an acute phase protein. This parallels enhanced TLR4 costimulatory activity. In vitro studies revealed that sMD-2 release appears to be restricted to endothelial and dendritic cells.Synonyms: Toll-like receptor 4
-
Gen-ID
- 7099
-
NCBI Accession
- NP_003257
-
UniProt
- O00206
-
Pathways
- TLR Signalweg, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Toll-Like Receptors Cascades, Inflammasome, S100 Proteine
Target
-